PharmaDispatch - BioPharmaDispatch

Latest News
December extensions for two cancer medicines

The listing of MSD's KEYTRUDA (pembrolizumab) will be extended to include its use as a first-line treatment in combination with chemotherapy while Amgen's BLINCYTO (blinatumomab) will be funded for early stage of acute lymphoblastic leukaemia.

Latest News Minister doubles-down on pharmacy tribunal November 20, 2019
The two appointments suggest Mr Hunt is acting to strengthen the government's hand as the negotiation of the Seventh Community Pharmacy Agreement stalls.
Latest News Companies, clinicians and patients welcome cancer listings November 20, 2019
Health minister Greg Hunt has announced the extended reimbursement of MSD's KEYTRUDA (pembrolizumab) and Amgen's leukaemia medicine BLINCYTO (blinatumomab).
Latest News BMS-Celgene merger set to close November 20, 2019
The US$74 billion merger of Bristol-Myers Squibb and Celgene is expected to close this week after being given the green light by the US regulator.
Latest News Industry better than most but more work required on gender pay gap November 19, 2019
The pharmaceutical industry performs better than others but the gender pay gap remains stubbornly stuck at almost 12.5 per cent.
Comment Rather than tinkering the push should be to start again November 19, 2019
If Australia was starting from scratch and constructing a system based on today's technologies, would it look like the one we have today?
Latest News Another confirmed industry leader for BioPharmaDispatch 2020 November 19, 2019
Another confirmed speaker to join Roche's Stuart Knight, GSK's Christi Kelsey and Neil MacGregor from Bristol-Myers Squibb, for the BioPharmaDispatch 2020 conference.
Latest News More criticism of PHARMAC as actor passes away November 19, 2019
Another day and another fierce criticism of New Zealand's PHARMAC with the death of one of the country's leading actors triggering yet more calls for reform of the agency.
Latest News Research reveals no link between statins and memory loss November 19, 2019
The release of research conducted over six years has found no link between cholesterol-lowering statins and memory loss.
Latest News This system is about 'rationing' not 'valuing' November 18, 2019
Decision-making on medicines is now subject to a terrible inequity under which rationed access is masked by ridiculous euphemisms like 'value' and 'affordability'.
Latest News 'Experts' gather in Sydney for meeting on value November 18, 2019
A group of 'experts' will gather in Sydney for a two-day private meeting to discuss the 'Challenges of Valuing and Paying for Combination Therapies in Oncology'.
Latest News New documents confirm focus on price and cost November 18, 2019
Publication of more public summary documents from the July PBAC meeting has confirmed the significant focus on cost as a reason for rejections and deferrals.

News of the Day

Latest Video

Most Read

New Stories